Salivary 8-OHdG: A useful biomarker for predicting severe ED and hypogonadism

Journal of Sexual Medicine

Volumn 5, Issue 6, 2008, Pages 1482-1491

  Yasuda, Mitsuko ^a   Ide, Hisamitsu ^a   Furuya, Kumiko ^a   Yoshii, Takashi ^a   Nishio, Kojiro ^a   Saito, Keisuke ^a   Isotani, Shuji ^a   Kamiyama, Yutaka ^a   Muto, Satoru ^a   Horie, Shigeo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Erectile Dysfunction; Oxidative Stress; Salivary 8 OHdG; Salivary Testosterone; Sildenafil

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; SILDENAFIL; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; ERECTILE DYSFUNCTION; EVENING DOSAGE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; MALE; OXIDATIVE STRESS; PENIS ERECTION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA ANALYSIS; SCORING SYSTEM; SHORT FORM 36; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; VOLUNTEER;

EID: 44949083518     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00821.x     Document Type: Article

References (50)

1. McCabe M, Matic H. Severity of ED: Relationship to treatment-seeking and satisfaction with treatment using PDE5 inhibitors. J Sex Med 2007; 4: 145-51.
2. Burnet AL. Novel nitric oxide signaling mechanisms regulate the erectile responses. Int J Impot Res 2004; 16: S15-9.
3. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38.
4. Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.
5. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci (Lond) 1997; 93: 519-25.
6. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: Endothelial dysfunction is the common denominator. Heart 2003; 89: 251-3.
7. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323-34.
8. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, DehòF, Montorsi F. Common grounds for erectile dysfunction and coronary artery disease. Curr Opinion Urol 2004; 14: 361-5.
9. Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999; 33: 420-4.
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87: 840-4.
11. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl 2006; 27: 335-47.
12. Morano S, Mandosi E, Fallarino M, Gatti A, Tiberti C, Sensi M, Gandini L, Buchetti B, Lenti L, Jannini EA, Lenzi A. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: A double-blind, placebo-controlled study. Eur Urol 2007; 52: 1758-76.
13. Hwang ES, Kim GH. Biomarkers for oxidative stress status of DNA, lipid, and proteins in vitro and in vivo cancer research. Toxicology 2007; 229: 1-10.
14. Kouloumenta V, Hatziefthimiou A, Paraskeva E, Gourgoulianis K, Molyvdas PA. Non-genomic effect of testosterone on airway smooth muscle. Br J Pharmacol 2006; 149: 1083-91.
15. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007; 167: 1252-60.
16. Guay A, Jacobson J. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 2007; 4: 1046-55.
17. Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 2002; 40: 1232-40.
18. Gori T, Sicuro S, Dragoni S, Donati G, Forconi S, Parker JD. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosinetriphosphate-sensitive potassium channels: A human in vivo study. Circulation 2005; 111: 721-3.
19. Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008; 29: 3-14.
20. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54: 346-51.
21. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57.
22. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (20 suppl): 22-33.
23. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
24. Sawamoto Y, Sugano N, Tanaka H, Ito K. Detection of priodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol Immunol 2005; 20: 216-20.
25. Yasuda M, Ide H, Horie S. Diagnostic significance of salivary testosterone measurement using both LC-MS and ELISA. J Urol 2007; 177: 228.
26. Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB. The "trouble"with salivary testosterone. Psychoneuroendocrinolgy 2004; 29: 1229-40.
27. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405-13.
28. Arregger AL, Contreras LN, Tumilasci OR, Aquilano DR, Cardoso EM. Salivary testosterone: A reliable approach to the diagnosis of male hypogonadism. Clin Endocrinol 2007; 67: 656-62.
29. International Society for the Study of the Aging Male (ISSAM) Web site. Available at: http://www.issam.ch/ (accessed on September 1, 2007).
30. Jeremy JY, Angelini GD, Khan M, Mikhailidis DP, Morgan RJ, Thompson CS, Bruckdorfer KR, Naseem KM. Platelets, oxidant stress and erectile dysfunction and hypothesis. Cardiovasc Res 2000; 46: 50-4.
31. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214-22.
32. Choi SM, Kim JE, Kang KK. Chronic treatment of DA-8159, a new phophodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive rat. Life Sci 2006; 78: 1211-6.
33. Serafini M, Villano D, Spera G, Pellegrini N. Redox molecules and cancer prevention: The importance of understanding the role of the antioxidant network. Nutr Cancer 2006; 56: 232-40.
34. Irie M, Tamae K, Iwamoto-Tanaka N, Kasai H. Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine. Cancer Sci 2005; 96: 600-6.
35. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 2005; 39: 553-60.
36. Behr-Roussel D, Gorny D, Mevel K, Caisey S, BernabéJ, Burgess G, Wayman C, Alexandre L, Giuliano F. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis. Eur Urol 2005; 47: 87-91.
37. Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002; 25: 1336-9.
38. Althof SE, O'leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, King R, Siegel RL, International SEAR Study Group. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med 2006; 3: 521-9.
39. Rhoden EL, Telöken C, Sogari PR, Souto CA. The relationship of serum testosterone to erectile function in normal aging men. J Urol 2002; 167: 1745-8.
40. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
41. Sternbach H. Age-associated testosterone decline in men: Clinical issues for psychiatry. Am J Psychiatry 1998; 155: 1310-8.
42. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004; 145: 2253-63.
43. Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Pandian MR, Galmarini M, Bhasin S. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 1993; 59: 1118-23.
44. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87: 589-98.
45. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335-43.
46. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 1996; 94: 2614-9.
47. Stoléru SG, Ennaji A, Cournot A, Spira A. LH pulsatile secretion and testosterone blood levels are influenced by sexual arousal in human males. Psychoneuroendocrinology 1993; 18: 205-18.
48. Jannini EA, Screponi E, Carosa E, Pepe M, Lo Giudice F, Trimarchi F, Benvenga S. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 1999; 22: 385-92.
49. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007; 116: 2694-701.
50. Greco EA, Pili M, Bruzziches R, Corona G, Spera G, Aversa A. Testosterone: Estradiol ratio changes associated with long-term tadalafil administration: A pilot study. J Sex Med 2006; 3: 716-22.